Evidence map›Paper›PMID 32954288›Full record

ArticleBrain communications2020

Prion protein codon 129 polymorphism in mild cognitive impairment and dementia: the Rotterdam Study.

Hata Karamujić-Čomić, Shahzad Ahmad, Thom S Lysen, Alis Heshmatollah, Gennady V Roshchupkin, Meike W Vernooij, Annemieke J M Rozemuller, Mohammad Arfan Ikram, Najaf Amin, Cornelia M van Duijn

Abstract read
In one paragraph

Article in Brain communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hata Karamujić-ČomićDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Shahzad AhmadDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Thom S LysenDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Alis HeshmatollahDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Gennady V RoshchupkinDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Meike W VernooijDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Annemieke J M RozemullerDepartment of Pathology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Mohammad Arfan IkramDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Najaf AminDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Cornelia M van DuijnDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.

Funding

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-ADU01AG061359 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KASTENMULLER, GABI · 2018 to 2022
$10.0M
Gut Liver Brain Biochemical Axis in Alzheimer's DiseaseRF1AG058942 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, VAN DUIJN, CORNELIA MARJA · 2018 to 2018
$3.4M
NIA NIH HHS RF1 AG058942NIA NIH HHS U01 AG061359
6 · The paper itself

Abstract

Creutzfeldt-Jakob disease is a rare, fatal, neurodegenerative disease caused by the accumulation of abnormally folded prion proteins. The common polymorphism at codon 129 (methionine/valine) in the prion protein (

Indexed as

dementiamild cognitive impairmentprions

Identifiers

PMID32954288
PMCPMC7425338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.